NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES
|
0.710 |
GermlineCausalMutation
|
disease |
ORPHANET |
A homozygous canonical splice acceptor site mutation in PRUNE1 is responsible for a rare childhood neurodegenerative disease in Manitoba Cree families.
|
30556349 |
2019 |
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
PRUNE is crucial for normal brain development and mutated in microcephaly with neurodevelopmental impairment.
|
28334956 |
2017 |
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
PRUNE is crucial for normal brain development and mutated in microcephaly with neurodevelopmental impairment.
|
28334956 |
2017 |
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Homozygous mutation in PRUNE1 in an Oji-Cree male with a complex neurological phenotype.
|
28211990 |
2017 |
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
NMIHBA was recently reported to be caused by PRUNE1 mutations.
|
29797509 |
2018 |
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic Disease.
|
26539891 |
2015 |
Microcephaly
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Microcephaly
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
PRUNE is crucial for normal brain development and mutated in microcephaly with neurodevelopmental impairment.
|
28334956 |
2017 |
Microcephaly
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Autosomal recessive PRUNE1 mutations are reported to cause a severe neurodevelopmental disorder with microcephaly, hypotonia, and brain malformations.
|
30556349 |
2019 |
Congenital clubfoot
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Exophthalmos
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Macrotia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Plagiocephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypoplasia of corpus callosum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Spastic tetraparesis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebellar atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Profound global developmental delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebral cortical atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Breast Carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
The identification of these two modes of inhibition of formation of the nm23-H1-h-prune protein complex pave the way toward new challenges, including translational studies using IC261 or this competitive peptide 'in vivo' to inhibit cellular motility induced by nm23-H1-h-prune complex formation during progression of breast cancer.
|
17906697 |
2008 |
Breast Carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
The h-prune gene is involved in cellular motility and metastasis formation in breast cancer through interacting with the nm23-H1 protein.
|
15671547 |
2005 |
Breast Carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
A similar situation was observed in all breast carcinomas with amplification of PRUNE.
|
11687967 |
2001 |
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
The h-prune gene is involved in cellular motility and metastasis formation in breast cancer through interacting with the nm23-H1 protein.
|
15671547 |
2005 |
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
The identification of these two modes of inhibition of formation of the nm23-H1-h-prune protein complex pave the way toward new challenges, including translational studies using IC261 or this competitive peptide 'in vivo' to inhibit cellular motility induced by nm23-H1-h-prune complex formation during progression of breast cancer.
|
17906697 |
2008 |